• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

World Experts to Discuss Future of Neurology at Inaugural International Congress


The first annual International Congress on the Future of Neurology convenes in New York City in September. Which thought leaders will be moderating?

Stephen Silberstein, MD

Fred Rincon, MD, MSc

Karl Doghramji, MD

Discovery and application of novel therapeutics for devastating disease is perhaps nowhere as critical as in clinical neurology. In September, in New York City, the first annual International Congress on the Future of Neurology will convene a unique group of world leaders in research and clinical practice to present new data and stimulate discussion on topics that span the discipline of neurology. 

The 2-day Congress, chaired by Stephen D. Silberstein, MD, professor of neurology and director of the Jefferson Headache Center in Philadelphia, will be held September 27-29, 2019, and focus on therapeutic developments and clinical decision making in 8 areas of neurologic disease: stroke, headache/migraine, epilepsy, movement disorders, neuromuscular disorders, multiple sclerosis, and dementia/Alzheimer disease.

Faculty representing leading academic medical centers in the US and Europe will moderate panel presentations, question and answer sessions, case studies, and other interactive formats designed to open dialogue on emerging therapies as well as encourage sharing of best practices across specific therapeutic areas.

Among the 8 thought leaders scheduled to present at the meeting in September are Fred Rincon, MD, MSc, and Karl Doghramji, MD, both of Thomas Jefferson Univerity in Philadelphia, Penn.

Fred Rincon, MD, MSc, division head of cerebrovascular disease at the Vicki and Jack Farber Institute for Neuroscience and associate professor of neurology and neurological surgery at Thomas Jefferson University, will moderate a session on stroke, titled "Novel Interventions in Stroke Care," where stroke experts will discuss limitations to current pharmacologic and surgical interventions; how to extend the treatment window for acute ischemic stroke; and promising  therapeutic approaches for hemorrhagic stroke.

Karl Doghramji, MD, professor of psychiatry, neurology, and medicine at Thomas Jefferson University, Medical Director, Jefferson Sleep Disorders Center, and Program Director, Fellowship in Sleep Medicine, will moderate the sleep disorders session, titled "Beyond Counting Sheep: Effective Therapies for Sleep Disorders." Topics covered will include new therapeutic approaches to insomnia; effective management of narcolepsy, including risks for therapeutic abuse; and, physiologic versus pharmacologic interventions for excessive daytime sleepiness and obstructive sleep apnea.

Moderators currently planned for the other 6 sessions: Alzheimer/dementia, Richard S. Isaacson, MD; Epilepsy, Elizabeth A. Thiele, MD, PhD; neuromuscular disease, Claudia A. Chiriboga, MD, MPH; multiple sclerosis, Thomas Leist, MD, PhD; movement disorders, Jeffrey B. Ratliff, MD; migraine, William Young, MD.

The full agenda for the 2 days is available here. For more information and to register, click here. Receive 25% off registration fees with code Neuro19SI.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
© 2024 MJH Life Sciences

All rights reserved.